APO RESEARCH · REPORT
Medical Polymers
The medical polymers market comprises resins and fibers, elastomers and biodegradable plastics that are used in various healthcare applications such as equipment and devices, packaging and tissue engineering. Polyvinyl chloride, polypropylene, polystyrene and polyethylene are the commonly used fibers and resins in the medical industry.
Product & engineering
Understand the product.
The medical polymers market comprises resins and fibers, elastomers and biodegradable plastics that are used in various healthcare applications such as equipment and devices, packaging and tissue engineering. Polyvinyl chloride, polypropylene, polystyrene and polyethylene are the commonly used fibers and resins in the medical industry.
Selected research
Industry Research
Medical Polymers Industry Research Report 2026
Market perspective
The medical polymers market comprises resins and fibers, elastomers and biodegradable plastics that are used in various healthcare applications such as equipment and devices, packaging and tissue engineering. Polyvinyl chloride, polypropylene, polystyrene and polyethylene are the commonly used fibers and resins in the medical industry.
The major players in global Medical Polymers market include BASF SE, Bayer, Celanese, DSM, Du Pont, etc. The top 5 players occupy about 20% shares of the global market. Europe and North America are main markets, they occupy over 60% of the global market. Medical Resins and Fibers is the main type, with a share about 80%. Medical Packaging is the main application, which holds a share about 50%.
Report Scope
Read the full market overview
This report quantifies the global Medical Polymers market in terms of revenue (US$ million) and, where applicable, sales volume (kt), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kt) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Polymers Market by Company
BASF SE
Bayer
Celanese
DSM
DuPont
Solvay
Eastman Chemical
Evonik
HEXPOL
Exxon Mobil
Formosa Plastics
INEOS
Victrex
Colorite Compounds
Raumedic
Kraton
Tianjin Plastics
Shanghai New Shanghua
Medical Polymers Segment by Type
Medical Resins and Fibers
Medical Elastomers
Biodegradable Plastics
Other
Medical Polymers Segment by Application
Medical Devices and Equipment
Medical Packaging
Others (Including Tissue Engineering and Cardio Stents)
Medical Polymers Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Polymers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Polymers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Polymers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Medical Polymers manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Medical Polymers by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Medical Polymers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medical Resins and Fibers
- Medical Elastomers
- Biodegradable Plastics
- Other
Applications
- Medical Devices and Equipment
- Medical Packaging
- Others (Including Tissue Engineering and Cardio Stents)
Companies covered
- BASF SE
- Bayer
- Celanese
- DSM
- DuPont
- Solvay
- Eastman Chemical
- Evonik
- HEXPOL
- Exxon Mobil
- Formosa Plastics
- INEOS
- Victrex
- Colorite Compounds
- Raumedic
- Kraton
- Tianjin Plastics
- Shanghai New Shanghua
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Medical Polymers Market Size (2021-2032)
- 2.2.2 Global Medical Polymers Sales (2021-2032)
- 2.2.3 Global Medical Polymers Market Average Price (2021-2032)
- 2.3 Medical Polymers by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Medical Resins and Fibers
- 2.3.3 Medical Elastomers
- 2.3.4 Biodegradable Plastics
- 2.3.5 Other
- 2.4 Medical Polymers by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Medical Devices and Equipment
- 2.4.3 Medical Packaging
- 2.4.4 Others (Including Tissue Engineering and Cardio Stents)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Medical Polymers Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Medical Polymers Sales (kt) of Manufacturers (2021-2026)
- 3.3 Global Medical Polymers Revenue of Manufacturers (2021-2026)
- 3.4 Global Medical Polymers Average Price by Manufacturers (2021-2026)
- 3.5 Global Medical Polymers Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Medical Polymers, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Medical Polymers, Product Type & Application
- 3.8 Global Manufacturers of Medical Polymers, Established Date
- 3.9 Global Medical Polymers Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 BASF SE
- 4.1.1 BASF SE Company Information
- 4.1.2 BASF SE Business Overview
- 4.1.3 BASF SE Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 BASF SE Medical Polymers Product Portfolio
- 4.1.5 BASF SE Recent Developments
- 4.2 Bayer
- 4.2.1 Bayer Company Information
- 4.2.2 Bayer Business Overview
- 4.2.3 Bayer Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bayer Medical Polymers Product Portfolio
- 4.2.5 Bayer Recent Developments
- 4.3 Celanese
- 4.3.1 Celanese Company Information
- 4.3.2 Celanese Business Overview
- 4.3.3 Celanese Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Celanese Medical Polymers Product Portfolio
- 4.3.5 Celanese Recent Developments
- 4.4 DSM
- 4.4.1 DSM Company Information
- 4.4.2 DSM Business Overview
- 4.4.3 DSM Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 DSM Medical Polymers Product Portfolio
- 4.4.5 DSM Recent Developments
- 4.5 DuPont
- 4.5.1 DuPont Company Information
- 4.5.2 DuPont Business Overview
- 4.5.3 DuPont Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 DuPont Medical Polymers Product Portfolio
- 4.5.5 DuPont Recent Developments
- 4.6 Solvay
- 4.6.1 Solvay Company Information
- 4.6.2 Solvay Business Overview
- 4.6.3 Solvay Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Solvay Medical Polymers Product Portfolio
- 4.6.5 Solvay Recent Developments
- 4.7 Eastman Chemical
- 4.7.1 Eastman Chemical Company Information
- 4.7.2 Eastman Chemical Business Overview
- 4.7.3 Eastman Chemical Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Eastman Chemical Medical Polymers Product Portfolio
- 4.7.5 Eastman Chemical Recent Developments
- 4.8 Evonik
- 4.8.1 Evonik Company Information
- 4.8.2 Evonik Business Overview
- 4.8.3 Evonik Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Evonik Medical Polymers Product Portfolio
- 4.8.5 Evonik Recent Developments
- 4.9 HEXPOL
- 4.9.1 HEXPOL Company Information
- 4.9.2 HEXPOL Business Overview
- 4.9.3 HEXPOL Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 HEXPOL Medical Polymers Product Portfolio
- 4.9.5 HEXPOL Recent Developments
- 4.10 Exxon Mobil
- 4.10.1 Exxon Mobil Company Information
- 4.10.2 Exxon Mobil Business Overview
- 4.10.3 Exxon Mobil Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Exxon Mobil Medical Polymers Product Portfolio
- 4.10.5 Exxon Mobil Recent Developments
- 4.11 Formosa Plastics
- 4.11.1 Formosa Plastics Company Information
- 4.11.2 Formosa Plastics Business Overview
- 4.11.3 Formosa Plastics Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Formosa Plastics Medical Polymers Product Portfolio
- 4.11.5 Formosa Plastics Recent Developments
- 4.12 INEOS
- 4.12.1 INEOS Company Information
- 4.12.2 INEOS Business Overview
- 4.12.3 INEOS Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 INEOS Medical Polymers Product Portfolio
- 4.12.5 INEOS Recent Developments
- 4.13 Victrex
- 4.13.1 Victrex Company Information
- 4.13.2 Victrex Business Overview
- 4.13.3 Victrex Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Victrex Medical Polymers Product Portfolio
- 4.13.5 Victrex Recent Developments
- 4.14 Colorite Compounds
- 4.14.1 Colorite Compounds Company Information
- 4.14.2 Colorite Compounds Business Overview
- 4.14.3 Colorite Compounds Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Colorite Compounds Medical Polymers Product Portfolio
- 4.14.5 Colorite Compounds Recent Developments
- 4.15 Raumedic
- 4.15.1 Raumedic Company Information
- 4.15.2 Raumedic Business Overview
- 4.15.3 Raumedic Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Raumedic Medical Polymers Product Portfolio
- 4.15.5 Raumedic Recent Developments
- 4.16 Kraton
- 4.16.1 Kraton Company Information
- 4.16.2 Kraton Business Overview
- 4.16.3 Kraton Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Kraton Medical Polymers Product Portfolio
- 4.16.5 Kraton Recent Developments
- 4.17 Tianjin Plastics
- 4.17.1 Tianjin Plastics Company Information
- 4.17.2 Tianjin Plastics Business Overview
- 4.17.3 Tianjin Plastics Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Tianjin Plastics Medical Polymers Product Portfolio
- 4.17.5 Tianjin Plastics Recent Developments
- 4.18 Shanghai New Shanghua
- 4.18.1 Shanghai New Shanghua Company Information
- 4.18.2 Shanghai New Shanghua Business Overview
- 4.18.3 Shanghai New Shanghua Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Shanghai New Shanghua Medical Polymers Product Portfolio
- 4.18.5 Shanghai New Shanghua Recent Developments
5 Global Medical Polymers Market Scenario by Region
- 5.1 Global Medical Polymers Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Medical Polymers Sales by Region: 2021-2032
- 5.2.1 Global Medical Polymers Sales by Region: 2021-2026
- 5.2.2 Global Medical Polymers Sales by Region: 2027-2032
- 5.3 Global Medical Polymers Revenue by Region: 2021-2032
- 5.3.1 Global Medical Polymers Revenue by Region: 2021-2026
- 5.3.2 Global Medical Polymers Revenue by Region: 2027-2032
- 5.4 North America Medical Polymers Market Facts & Figures by Country
- 5.4.1 North America Medical Polymers Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Medical Polymers Sales by Country (2021-2032)
- 5.4.3 North America Medical Polymers Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Medical Polymers Market Facts & Figures by Country
- 5.5.1 Europe Medical Polymers Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Medical Polymers Sales by Country (2021-2032)
- 5.5.3 Europe Medical Polymers Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Medical Polymers Market Facts & Figures by Country
- 5.6.1 Asia Pacific Medical Polymers Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Medical Polymers Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Medical Polymers Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Medical Polymers Market Facts & Figures by Country
- 5.7.1 South America Medical Polymers Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Medical Polymers Sales by Country (2021-2032)
- 5.7.3 South America Medical Polymers Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Medical Polymers Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Medical Polymers Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Medical Polymers Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Medical Polymers Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Medical Polymers Sales by Type (2021-2032)
- 6.1.1 Global Medical Polymers Sales by Type (2021-2032) & (kt)
- 6.1.2 Global Medical Polymers Sales Market Share by Type (2021-2032)
- 6.2 Global Medical Polymers Revenue by Type (2021-2032)
- 6.2.1 Global Medical Polymers Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Medical Polymers Revenue Market Share by Type (2021-2032)
- 6.3 Global Medical Polymers Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Medical Polymers Sales by Application (2021-2032)
- 7.1.1 Global Medical Polymers Sales by Application (2021-2032) & (kt)
- 7.1.2 Global Medical Polymers Sales Market Share by Application (2021-2032)
- 7.2 Global Medical Polymers Revenue by Application (2021-2032)
- 7.2.1 Global Medical Polymers Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Medical Polymers Revenue Market Share by Application (2021-2032)
- 7.3 Global Medical Polymers Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Medical Polymers Value Chain Analysis
- 8.1.1 Medical Polymers Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Medical Polymers Production Mode & Process
- 8.2 Medical Polymers Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Medical Polymers Distributors
- 8.2.3 Medical Polymers Customers
9 Global Medical Polymers Analyzing Market Dynamics
- 9.1 Medical Polymers Industry Trends
- 9.2 Medical Polymers Industry Drivers
- 9.3 Medical Polymers Industry Opportunities and Challenges
- 9.4 Medical Polymers Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst